SWOG clinical trial number
SWOG-7438

Cis-Diamminedichloroplatinum (II)(NSC-119875, CACP) for Malignancies of the Gynecologic and Genitourinary Organs

Closed
Abbreviated Title
Cis-Diamminedichloroplatinum (II)(NSC-119875, CACP) for Malignancies of the Gynecologic and Genitourinary Organs
Activated
01/09/1975
Closed
01/26/1977

Publication Information Expand/Collapse

1979

Phase II evaluation of cis-dichlorodiammineplatinum (II) in advanced malignancies of the genitourinary and gynecologic organs: A Southwest Oncology Group study.

A Rossof;R Talley;R Stephens;T Thigpen;M Samson;C Groppe Jr;H Eyre;R Fisher Cancer Treat Rep 63(9-10):1557-1564

Phase II evaluation of cis-dichlorodiammineplatinum (II) in advanced malignancies of the genitourinary and gynecologic organs: A Southwest Oncology Group study.

A Rossof;R Talley;R Stephens;T Thigpen;M Samson;C Groppe Jr;H Eyre;R Fisher Cancer Treat Rep 63(9-10):1557-1564

1977

Phase II evaluation of single high-dose cis-diamminedi- chloroplatinum (II) (NSC-119875, CACP) in gynecologic *GYN) and genitourinary (GU) neoplasia.

AH Rossof;RW Talley;RL Stephens AACR, #388

Phase II evaluation of single high-dose cis-diamminedi- chloroplatinum (II) (NSC-119875, CACP) in gynecologic *GYN) and genitourinary (GU) neoplasia.

AH Rossof;RW Talley;RL Stephens AACR, #388